Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis.
Sebastian Felix Nepomuk BodeHannes RappNadine LienertHeike AppelDorit FabriciusPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
Highly effective CFTR-modulator therapy has a significant positive impact on both subjective and objective sinunasal symptoms in patients with CF and some improvement could be demonstrated in children < 18 years as well.